Orbis Allan Gray’s Merck MRK Stock Holding History

Orbis Allan Gray’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-292,953	Closed	-$23.2M	–	61
2019 Q1	$23.2M	Sell	292,953 -430,963	-60%	-$32.2M	0.16%	34
2018 Q4	$52.8M	Sell	723,916 -104,244	-13%	-$7.36M	0.38%	33
2018 Q3	$56.1M	Buy	828,160 +42,054	+5%	+$2.68M	0.32%	36
2018 Q2	$45.5M	Buy	786,106 +1,045	+0.1%	+$59K	0.25%	41
2018 Q1	$40.8M	Buy	785,061 +72,686	+10%	+$3.93M	0.23%	43
2017 Q4	$38.2M	Buy	712,375 +124,768	+21%	+$6.92M	0.22%	41
2017 Q3	$35.9M	Buy	+587,607	New	+$35.6M	0.22%	45
2016 Q4	–	Sell	-662,886	Closed	-$39.5M	–	70
2016 Q3	$39.5M	Sell	662,886 -3,153,997	-83%	-$184M	0.28%	48
2016 Q2	$210M	Sell	3,816,883 -932,127	-20%	-$49.6M	1.6%	20
2016 Q1	$240M	Buy	+4,749,010	New	+$233M	1.95%	17

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Orbis Allan Gray's MRK Position: Q2 2019 in Review

Orbis Allan Gray sold out of Merck (MRK) in Q2 2019, closing a stake of 292,953 shares — an estimated $23.2M sold.

Orbis Allan Gray first reported a position in MRK in Q1 2016 and held it in 10 quarters. The position peaked at $240M in Q1 2016. 2,299 funds tracked by Wall St. Rank hold MRK as of Q2 2019.

Orbis Allan Gray reported no remaining Merck position as of Q2 2019 after selling out during the quarter.
Orbis Allan Gray sold 292,953 Merck shares in Q2 2019, an estimated $23.2M.
Orbis Allan Gray first reported a position in Merck in Q1 2016 and held it in 10 quarters.
Orbis Allan Gray's Merck position peaked at $240M in Q1 2016.
2,299 funds tracked by Wall St. Rank held Merck as of Q2 2019.

Based on Orbis Allan Gray's 13F filing for Q2 2019, filed 14 Aug 2019.